← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Salus Discovery, Llc
Madison, WI
$7,814,378
Total funding
9
Grants
Funding over time
peak $1.9M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,814,378 · 9
By mechanism
R44$6,039,373 · 4
R43$1,476,262 · 4
N43$298,743 · 1
Investigators at Salus Discovery, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$1,000,000
R44 · FY2025 · AI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$962,850
R44 · FY2022 · HD
Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$916,195
R44 · FY2025 · AI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$818,507
R44 · FY2024 · HD
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$535,014
R44 · FY2017 · GM
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$533,801
R44 · FY2018 · GM
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$436,366
R44 · FY2020 · HD
Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
R43 · FY2018 · OD
Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
R43 · FY2017 · OD
Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$300,000
R44 · FY2024 · AI
IGF::OT::IGF THE MICROVOA: ENHANCING THE VIRAL OUTGROWTH ASSAY (VOA) WITH MICROTECHNOLOGY$298,743
N43 · FY2016 · AI
3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$295,893
R44 · FY2024 · AI
3STEP: A swab-seal-read, point-of-care nucleic acid test to address disparity in STI screening and prevention$275,736
R43 · FY2024 · AI
Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology$275,526
R43 · FY2023 · AI
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$240,747
R44 · FY2016 · GM
Development of a cell based assay to assess antigen specific tolerance$225,000
R43 · FY2018 · AI